Additionally, febuxostat significantly decreased plasma insulin concentrations in CL-fed mice under fasting conditions (Fig. 2c), resulting in lower homeostasis model assessment of insulin resistance (HOMA-IR), a marker for insulin resistance (Fig. 2d). Here, INS is linked to Insulin resistance.